10 Jul 2025 | Sem categoria
Technophage S.A., a clinical-stage biopharmaceutical company focused on developing innovative therapies for areas of unmet medical need, today announces the initiation of a Phase 1b/2a clinical trial to evaluate TZ-161 for the treatment of acute spinal cord...
28 Nov 2023 | Sem categoria
We are thrilled to announce that Technophage has been recognized by IAPMEI, I.P. – Agência para a Competitividade e Inovação (Agency for Competitiveness and Innovation) with the prestigious ‘PME Líder’ distinction for the year 2023! This...
